BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28839394)

  • 21. A prospective study of iridial pigmentation and eyelash changes due to ophthalmic treatment with latanoprost.
    Chiba T; Kashiwagi K; Ishijima K; Furuichi M; Kogure S; Abe K; Chiba N; Tsukahara S
    Jpn J Ophthalmol; 2004; 48(2):141-7. PubMed ID: 15060793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acquired eyelash trichomegaly and alopecia areata in a human immunodeficiency virus-infected patient.
    Grossman MC; Cohen PR; Grossman ME
    Dermatology; 1996; 193(1):52-3. PubMed ID: 8864621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia.
    Blume-Peytavi U; Lönnfors S; Hillmann K; Garcia Bartels N
    J Am Acad Dermatol; 2012 May; 66(5):794-800. PubMed ID: 21875758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Essential trichomegaly: case report.
    Rossetto JD; Nascimento H; Muccioli C; Belfort R
    Arq Bras Oftalmol; 2013; 76(1):50-1. PubMed ID: 23812530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eyelash loss associated with hyperthyroidism.
    Jordan DR; Ahuja N; Khouri L
    Ophthalmic Plast Reconstr Surg; 2002 May; 18(3):219-22. PubMed ID: 12021655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ocular side effects and trichomegaly of eyelashes induced by erlotinib: a case report and review of the literature.
    Celik T; Kosker M
    Cont Lens Anterior Eye; 2015 Feb; 38(1):59-60. PubMed ID: 25249292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eyelash growth induced by topical prostaglandin analogues, bimatoprost, tafluprost, travoprost, and latanoprost in rabbits.
    Giannico AT; Lima L; Russ HH; Montiani-Ferreira F
    J Ocul Pharmacol Ther; 2013 Nov; 29(9):817-20. PubMed ID: 23981234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost.
    Johnstone MA
    Am J Ophthalmol; 1997 Oct; 124(4):544-7. PubMed ID: 9323945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative analysis of eyelash lengthening following topical latanoprost therapy.
    Sugimoto M; Sugimoto M; Uji Y
    Can J Ophthalmol; 2002 Oct; 37(6):342-5. PubMed ID: 12422916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Eyelash alterations in anophthalmic patients].
    Narikawa S; Schellini SA; Padovani CR; Padovani CR
    Arq Bras Oftalmol; 2007; 70(1):51-4. PubMed ID: 17505719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hair disorders associated with autoimmune connective tissue diseases.
    Cassano N; Amerio P; D'Ovidio R; Vena GA
    G Ital Dermatol Venereol; 2014 Oct; 149(5):555-65. PubMed ID: 24975949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trichomegaly induced by topical tacrolimus for the treatment of periorbital vitiligo: A brief report of a new adverse effect.
    Molés-Poveda P; Cowen EW
    Pediatr Dermatol; 2019 Jul; 36(4):e95-e96. PubMed ID: 31070265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Congenital trichomegaly, pigmentary degeneration of the retina and growth retardation (Oliver-McFarlane syndrome): 28-year follow-up of the first reported case.
    Chang TS; McFarlane DC; Oliver G; Willis NR
    Can J Ophthalmol; 1993 Jun; 28(4):191-3. PubMed ID: 8343920
    [No Abstract]   [Full Text] [Related]  

  • 34. Congenital trichomegaly (Oliver-McFarlane syndrome): a case report with 9 years' follow up.
    Haritoglou C; Rudolph G; Kalpadakis P; Boergen KP
    Br J Ophthalmol; 2003 Jan; 87(1):119-20. PubMed ID: 12488276
    [No Abstract]   [Full Text] [Related]  

  • 35. Biology of the eyelash hair follicle: an enigma in plain sight.
    Paus R; Burgoa I; Platt CI; Griffiths T; Poblet E; Izeta A
    Br J Dermatol; 2016 Apr; 174(4):741-52. PubMed ID: 26452071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eyelash trichomegaly associated with systemic tacrolimus.
    Ward KM; Barnett C; Fox LP; Grossman ME
    Arch Dermatol; 2006 Feb; 142(2):248. PubMed ID: 16490862
    [No Abstract]   [Full Text] [Related]  

  • 37. Erlotinib induced trichomegaly of the eyelashes.
    Jeon SH; Ryu JS; Choi GS; Kim JS; Kwon HY; Kim MS; Nam HS; Cho JH; Kwak SM; Lee HL; Kim HJ; Hong GJ
    Tuberc Respir Dis (Seoul); 2013 Jan; 74(1):37-40. PubMed ID: 23390452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy of latanoprost in the treatment of alopecia areata of eyelashes and eyebrows.
    Faghihi G; Andalib F; Asilian A
    Eur J Dermatol; 2009; 19(6):586-7. PubMed ID: 19620039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of Bimatoprost-Induced changes on Rabbits eyelash Follicle: Clinical and Electron microscopic study.
    Sayed KM; Mostafa EM; Mounir A; Abd Elhaliem NG; Alsmman AH
    Clin Ophthalmol; 2019; 13():2421-2426. PubMed ID: 31824136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eyelash transplantation using leg hair by follicular unit extraction.
    Umar S
    Plast Reconstr Surg Glob Open; 2015 Mar; 3(3):e324. PubMed ID: 25878935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.